Table 2. Adjusted Logistic Regression Result (Outcome: PPM, n = 255).
Valve size of 20 mm (14 observations) omitted due to no observation in the PPM group
A fib: atrial fibrillation; BMI: body mass index; Cr: creatinine; Hb: hemoglobin; HF: heart failure; LVIDd: left ventricular internal diameter diastolic; LVIDs: left ventricular internal diameter systolic; MI: myocardial infarction; NYHA: New York Heart Association; O2: oxygen; PPM: permanent pacemaker; STS Score: Society of Thoracic Surgeons Score
| Covariates | Odds Ratio | P-value | 95% Confidence Interval | |
| Age | 1.03 | 0.623 | 0.92 | 1.15 |
| Male | 0.09 | 0.088 | 0.01 | 1.44 |
| Smoker | 22.56 | 0.068 | 0.80 | 640.04 |
| STS score | 1.08 | 0.460 | 0.88 | 1.33 |
| BMI (Ref: Normal) | ||||
| Underweight | 2.01 | 0.603 | 0.14 | 27.92 |
| Overweight | 12.77 | 0.024 | 1.39 | 17.25 |
| Obese | 15.02 | 0.036 | 1.19 | 19.92 |
| Hb pre-procedure | 1.73 | 0.025 | 1.07 | 2.79 |
| Cr. pre-procedure | 0.68 | 0.552 | 0.19 | 2.40 |
| LVIDs | 0.41 | 0.311 | 0.07 | 2.30 |
| LVIDd | 3.12 | 0.246 | 0.46 | 21.22 |
| Septal wall ≥ 1.1 (Ref: < 1.1) | 0.68 | 0.728 | 0.08 | 5.82 |
| Valve size (Ref: 23 mm) | ||||
| 26 mm | 8.34 | 0.078 | 0.79 | 88.32 |
| 29 mm | 20.21 | 0.046 | 1.06 | 385.36 |
| Moderate anesthesia | 0.64 | 0.642 | 0.10 | 4.26 |
| Prior NYHA III-IV | 0.57 | 0.585 | 0.07 | 4.32 |
| Chronic lung disease (Ref: None) | ||||
| Mild | 1.48 | 0.675 | 0.24 | 9.31 |
| Moderate | 1.22 | 0.853 | 0.15 | 10.07 |
| Severe | 0.01 | 0.096 | 9.3E-05 | 2.12 |
| Diabetes | 0.72 | 0.665 | 0.16 | 3.21 |
| Home O2 | 1.11 | 0.944 | 0.06 | 22.52 |
| Immunosuppression | 1.37 | 0.821 | 0.09 | 20.33 |
| Prior MI | 1.18 | 0.836 | 0.25 | 5.65 |
| Prior HF | 2.33 | 0.448 | 0.26 | 20.75 |
| Hypertension | 0.19 | 0.168 | 0.02 | 2.00 |
| A fib/flutter | 2.74 | 0.160 | 0.67 | 11.13 |
| Conduction Defect | 14.40 | 0.009 | 1.97 | 105.13 |